AAGYLUR
NDC 70709-102, Penicillamine, capsule, from Cycle Pharmaceuticals Ltd..
- Product NDC
- 70709-102
- Status
- Listed
- Labeler
- Cycle Pharmaceuticals Ltd.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213293
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70709-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PENICILLAMINE250 mg/1
Pharmacologic classes
Antirheumatic Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70709-102-10 | 70709010210 | 100 CAPSULE in 1 BOTTLE (70709-102-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ddbd84a9-1c39-42e0-a271-138784e1dc58
Use it
Look up 70709-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70709-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70709-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.